Liver cancer specialists at Mayo Clinic Comprehensive Cancer Center offer hope to patients in the form of the highest quality therapies available. At the Cancer Center, patients with liver cancer may have access to personalized chemotherapy regimens, proton beam and other highly focused radiation therapies, prostate-specific membrane antigen (PSMA) therapy, and next-generation sequencing, as well as access to investigator-initiated clinical trials.
Mayo Clinic specialists work with one another in tumor boards and with patients' care teams at home. They do this to ensure the most appropriate treatment options are made available to the patient either at Mayo Clinic or at the local medical facility.
Mayo Clinic has prided itself on a culture of innovation and always pushing the envelope in terms of developing cutting edge treatments for cancer and all diseases. We continue to develop new treatment modalities whether that's individualized medicine by selecting chemotherapy agents based on the genetics of their tumor. To evolving radiation therapy including proton beam therapy and highly focused radiation. We're working on a couple different cancer clinical trials here at Mayo Clinic Rochester utilizing specialized imaging. It's called P. S. M. A. Or it stands for prostate specific memory and androgen. We're combining this type of pet imaging with both C. T. R. M. R. I. To better detect liver cancer. If we can detect this liver cancer with this type of pet scanning, we can very similarly then treat it with another type of drug that targets the same aspect that the pet scanning agent does. But the beautiful thing about it is we can image the cancer with the agent. We can treat it with a similar agent and then after we give the treatment we can actually follow with that pet scanning again to determine is the treatment working when looking at patients that have disease that is conventionally more advanced. We now have several clinical trials multiple which are investigator initiated where we're combining techniques such as radio mobilization. In addition to immunotherapy with better diagnostic techniques um ability to look at tumor markers and even genetic data on tumors. The ability to narrow down to where it came from has increased a lot a lot of times these patients come in with complex presentation whether anatomically their masses in a location where it may be difficult for one provider, just come up with a single plan. We may need, you know, everybody's input to come up with the best plan. We're fortunate lucky at Mayo Clinic that our sites have phenomenal teams that offer all treatment modalities and have a high volume of liver cancer patients, the primary liver cancer, calandra carcinoma. A number of seminal discoveries were made at Mayo Clinic. Through these genetic sequencing approaches that were undertaken were targeted treatments too. A marker called fibroblast growth factor receptor two F g f R two has led to targeted treatments that are pills that can be used for these patients instead of chemotherapies are tumor board is really the central focus of our patient centered activity. It's where we make the most decisions to really discuss what the best treatment options are for each individual patient and then how to enact that plan with their local providers. When a patient is diagnosed with liver cancer, they're looking for alternate options that are possible to them. And here at the Mayo Clinic, we are always trying to stretch that boundary. We have tremendous experience and expertise in this area. We can offer hope in times when there seems to be none